The Global Cell Therapy Packaging Products and Services Market size was accounted at USD 241.55 Mn in 2021; It is projected to grow at a compound annual growth rate (CAGR) of 20.32% from 2022 to 2030. Cell and gene therapies are growing at a rapid rate. Cell therapy includes the introduction of live cells into a patient’s body to repair or replace damaged tissues The increasing advancements in packaging and labelling are expected to drive the growth of the cell therapy packaging products and services market during the forecast period. As gene and cell therapy are gaining more acceptance, companies involved in logistics will require exceptional technology and novel ways to address supply chain issues. Further, suppliers of supply chain solutions will need a cold chain logistic network and cryogenic facilities to facilitate investigations and evaluate the safety and efficacy of cell and gene treatments. For instance, In Jan 2022, Catalent expanded its cold chain packaging capabilities at its Philadelphia location to meet the rising demand for biological medication delivery and breakthrough cell and gene treatments. The new suites offer complete serialization capabilities specially tailored for small-scale commercial product quantities.
Major driving factors in the market of cell therapy packaging products and services are the increasing need for cell and gene therapies, the high prevalence of cancer diseases and the rising number of clinical trials. Furthermore, advanced medical technologies, the growing trend of outsourcing in the healthcare industry, and the ongoing efforts of service providers to further improve their portfolios are enhancing the growth of the cell therapy packaging products and services market. However, the high cost of manufacturing systems, lack of standard therapy protocols, and shortage of skilled professionals limit the growth of this market.
Segmentation of cell therapy packaging products and services market includes Therapy, Package Engineering Design, Scale of Operation, and Region. The Therapy segment is segmented into T-cell Therapies, Dendritic Cell Vaccines, Stem Cell Therapies, NK Cell Therapies, and Other ATMPs. T-cell Therapies will be the key segment to drive the growth of this market. By Scale of Operation, the market is divided into Clinical and Commercial. In terms of Package Engineering Design, the market can be divided into Primary Packaging and Secondary Packaging. Based on the region, the cell therapy packaging products and services market is categorized into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. North America, followed by Europe, hold the maximum share of this market due to increased research and development expenditure, the presence of significant market players and the fast adoption of advanced technologies.
Major key Players in the cell therapy packaging products and services market are Almac, Catalent Pharma Solutions, Cryoport Systems, Core Cryolab Inc., Yourway, Lufthansa Cargo, Saint-Gobain Life Sciences, Thermo Fisher Scientific, Sharp, West Pharmaceutical Services, Chart Industries Inc., and Other Prominent Players.
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 based on Package Engineering Design
